NQO1 and GCLC may be responsible for tamoxifen resistance in breast cancer
A research team from the University of Salford (Manchester, UK) has identified two new molecular targets that may be responsible for tamoxifen resistance in breast cancer.
Please sign in or register for FREE to view this content
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.